EspAddText
EspRemoveText
|
CMA Recommendations on Vaccine Equity and Intellectual Property
|
Parliamentary submission
|
2022
|
EspAddText
EspRemoveText
|
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use
|
Policy endorsement
|
2021
|
EspAddText
EspRemoveText
|
Taking action on drug shortages during Covid-19 - open letter
|
Parliamentary submission
|
2020
|
EspAddText
EspRemoveText
|
Authorizing Cannabis for Medical Purposes
|
Policy document
|
2020
|
EspAddText
EspRemoveText
|
Health Canada consultation on reducing youth access and appeal of vaping products
|
Response to consultation
|
2019
|
EspAddText
EspRemoveText
|
Cannabis for Medical Purposes
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
Medication use and seniors (Update 2017)
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
Vision for e-Prescribing: a joint statement by the Canadian Medical Association and the Canadian Pharmacists Association
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
Health Canada consultation on edible cannabis, extracts & topicals
|
Response to consultation
|
2019
|
EspAddText
EspRemoveText
|
Health Canada consultation on Canadian drugs and substances strategy
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Implementation of National Pharmacare
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Support life-saving supervised consumption and overdose prevention sites: open letter to Premier Doug Ford and Health Minister Christine Elliott
|
Policy endorsement
|
2018
|
EspAddText
EspRemoveText
|
Health Canada consultation on regulatory amendments regarding tramadol
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Health Canada consultation on restriction of marketing and advertising of opioids
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Consultation on proposed front-of-package labelling
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Bill C-45: The Cannabis Act
|
Parliamentary submission
|
2018
|
EspAddText
EspRemoveText
|
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
|
Parliamentary submission
|
2018
|
EspAddText
EspRemoveText
|
Proposed approach to the regulation of cannabis
|
Response to consultation
|
2018
|
EspAddText
EspRemoveText
|
Excise duty framework for cannabis products
|
Response to consultation
|
2017
|